Cargando…

Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis

BACKGROUND: Immune system dysfunction is a hypothesis in the psychopathology of schizophrenia, but the impact of antipsychotic treatment within this system is not clear. The aim of this meta-analysis was to investigate the impact of antipsychotic treatment on cytokine levels in in vivo studies on sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romeo, Bruno, Brunet-Lecomte, Marine, Martelli, Catherine, Benyamina, Amine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119290/ https://www.ncbi.nlm.nih.gov/pubmed/30016466 http://dx.doi.org/10.1093/ijnp/pyy062

Ejemplares similares

The Modulated Role of Toxoplasma gondii on Eosinophils in Psychiatric Disorders after Cannabis Cessation
por: Romeo, Bruno, et al.
Publicado: (2023)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

Peripheral Amino Acid Levels in Schizophrenia and Antipsychotic Treatment
por: De Luca, Vincenzo, et al.
Publicado: (2008)

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics
por: Liu-Seifert, Hong, et al.
Publicado: (2011)

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia
por: McCutcheon, R., et al.
Publicado: (2017)

Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review
por: Sentissi, Othman, et al.
Publicado: (2008)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Neuropsychological Impairment in Detoxified Alcohol-Dependent Subjects with Preserved Psychosocial Functioning
por: Martelli, Catherine, et al.
Publicado: (2017)

The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users
por: Benyamina, Amine
Publicado: (2014)

A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
por: Marcinowicz, Piotr, et al.
Publicado: (2021)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

The heterogeneity of antipsychotic response in the treatment of schizophrenia
por: Case, M., et al.
Publicado: (2011)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
por: Wu, Haishan, et al.
Publicado: (2013)

Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
por: Mizuno, Yuya, et al.
Publicado: (2019)

Association between Serum Cortisol and DHEA-S Levels and Response to Antipsychotic Treatment in Schizophrenia
por: Babinkostova, Zoja, et al.
Publicado: (2015)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
por: Pae, Chi-Un
Publicado: (2020)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment
por: Reynolds, Gavin P, et al.
Publicado: (2021)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Antipsychotic treatment and cognitive function in patients with schizophrenia
por: Tumova, M. A., et al.
Publicado: (2023)

Caudate gray matter volumes and risk of relapse in Type A alcohol-dependent patients: A 7-year MRI follow-up study
por: Martelli, Catherine, et al.
Publicado: (2023)

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis
por: Balijepalli, Chakrapani, et al.
Publicado: (2018)

The Efficacy and Heterogeneity of Antipsychotic Response in Schizophrenia: A Meta-analysis
por: McCutcheon, Robert A., et al.
Publicado: (2021)

Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics
por: Crespo-Facorro, Benedicto, et al.
Publicado: (2015)

Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects
por: Gabay, Anthony S, et al.
Publicado: (2015)

S235. MAINTENANCE TREATMENT WITH ANTIPSYCHOTIC DRUGS IN SCHIZOPHRENIA – SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
por: Schneider-Thoma, Johannes, et al.
Publicado: (2018)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022)

The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
por: Druyts, Eric, et al.
Publicado: (2014)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Ren, Xinhua S, et al.
Publicado: (2009)

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
por: Faries, Douglas E, et al.
Publicado: (2009)

Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
por: Barak, Yoram, et al.
Publicado: (2012)

Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
por: Lally, John, et al.
Publicado: (2016)

The debate regarding maintenance treatment with antipsychotic drugs in schizophrenia
por: Davidson, Michael
Publicado: (2018)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

T8. ANTIPSYCHOTIC TREATMENT AND EYE MOVEMENT ABNORMALITIES IN SCHIZOPHRENIA
por: Takahashi, Junichi, et al.
Publicado: (2020)

Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
por: Manchia, Mirko, et al.
Publicado: (2021)

Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia
por: Lieslehto, Johannes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0rlgdv7stk96jufc3odchbi6ii